19 annual accounts with figures on one time axis, 21 filings since 2005
peak of €356,090 in 2016
€206,785▼ 27.3%
lowest -€87,611 in 2010
-€35,484▼ €80,792
peak of €141,070 in 2024
€105,586▼ 25.2%
€2.0m▲ 22.4%
peak of 1.5 FTE in 2012
-not published
Board2 names since 2014
1 directorName after signing inVisible after signing in
Documentsfilings and deeds
24-12-202538 days before the deadline
2025micro format
Gross margin from €284,567 to €206,785Loss of €35,484Equity from €141,070 to €105,586Debts from €1.7m to €2.0mInvestments €521,783Cash from €24,688 to €2,675
Lower net result than 95% of companies in human health. Sector median €59,553 · 21,334 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 1,104 companies had the same profile as KARAR MEDICAL has now. Each dot stands for 3 companies, two years later.
94.3%
were still trading
3.5%
stopped another way
1.8%
went bankrupt
Small
20 years or older
solvency under 10%
a small loss
Another 0.4% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,104 companies, not a prediction for KARAR MEDICAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0862455407
Name hiddenVisible after signing in changes role from manager to director
Director discharge: Hidden nameVisible after signing in · Gazette deed
New managerName after signing inVisible after signing in appointed, Name hiddenVisible after signing in resigned · General meeting of 04-10-2016 · Gazette deed
Hidden nameVisible after signing in reappointed as manager
General meeting of 26-12-2014 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as KARAR MEDICAL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2m and €2.2m, founded between 2002 and 2007.
The company number of KARAR MEDICAL is 0862.455.407. The VAT number is the same number with BE in front: BE 0862.455.407.
Where is KARAR MEDICAL based?
The registered office is at Franklin Rooseveltlaan 135, 1050 Brussels.Company details
What does KARAR MEDICAL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of KARAR MEDICAL?
KARAR MEDICAL is a private limited company (BV).
When was KARAR MEDICAL founded?
KARAR MEDICAL was founded on 31-12-2003.
Is KARAR MEDICAL still active?
Yes, KARAR MEDICAL is an active enterprise in the KBO register.
How many employees does KARAR MEDICAL have?
KARAR MEDICAL had an average of 1 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of KARAR MEDICAL?
The turnover in financial year 2025 is ≈ €380,000. This figure is estimated from the gross margin of €206,785 and 40 comparable companies (NACE 86220). It probably lies between €330,000 and €510,000.
Is KARAR MEDICAL profitable?
In financial year 2025, KARAR MEDICAL made a loss of €35,484.
Where can I find the annual accounts of KARAR MEDICAL?
KARAR MEDICAL filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of KARAR MEDICAL due?
KARAR MEDICAL must file the annual accounts for financial year 2026 by 31-01-2027.Timeline